HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
2 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ZAR1L
zygote arrest 1 like
Chromosome 13 Β· 13q13.1
NCBI Gene: 646799Ensembl: ENSG00000189167.12HGNC: HGNC:37116UniProt: A6NP61
8PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
intracellular membraneless organellemRNA 3'-UTR bindingoocyte maturationnegative regulation of translationHereditary breast and ovarian cancer syndromehereditary breast ovarian cancer syndromebreast-ovarian cancer, familial, susceptibility to, 2dyshidrosis
✦AI Summary

Based on limited published evidence, ZAR1L is an mRNA-binding protein required for maternal mRNA storage, translation, and degradation during oocyte maturation. It binds to the 3'-UTR of maternal mRNAs and inhibits their translation in immature oocytes 1. ZAR1L undergoes liquid-liquid phase separation to form membraneless compartments storing maternal mRNAs. The conserved C-terminal CxxC domain is functionally critical 1. ZAR1L colocalizes with P-body and chr13 body components, suggesting roles in RNA regulation during early embryonic development 2. Its dominant-negative expression causes two-cell-stage embryonic arrest with altered histone methylation patterns 2.

Sources cited
1
ZAR1L (ZAR2) binds maternal transcripts and inhibits translation in oocytes; conserved C-terminal CxxC domain is functionally important
PMID: 35072788
2
ZAR1L colocalizes with P-body and chromatoid body components; dominant-negative mutant causes two-cell-stage embryonic arrest with altered histone methylation
PMID: 20014101
⚠Limited data available β€” This gene has 2 indexed publications. Summary and analysis may be incomplete.
Disease Associationsβ“˜20
Hereditary breast and ovarian cancer syndromeOpen Targets
0.36Weak
hereditary breast ovarian cancer syndromeOpen Targets
0.36Weak
breast-ovarian cancer, familial, susceptibility to, 2Open Targets
0.34Weak
dyshidrosisOpen Targets
0.29Weak
neurodegenerative diseaseOpen Targets
0.16Weak
schizophreniaOpen Targets
0.07Suggestive
actinic keratosisOpen Targets
0.06Suggestive
HypercholesterolemiaOpen Targets
0.05Suggestive
skin cancerOpen Targets
0.05Suggestive
squamous cell carcinomaOpen Targets
0.05Suggestive
basal cell carcinomaOpen Targets
0.05Suggestive
non-melanoma skin carcinomaOpen Targets
0.04Suggestive
squamous cell lung carcinomaOpen Targets
0.04Suggestive
hypothyroidismOpen Targets
0.04Suggestive
placenta praeviaOpen Targets
0.04Suggestive
Abruptio PlacentaeOpen Targets
0.03Suggestive
hyperlipidemiaOpen Targets
0.03Suggestive
metabolic diseaseOpen Targets
0.03Suggestive
response to statinOpen Targets
0.03Suggestive
Abnormality of refractionOpen Targets
0.03Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar β†—
Related Genes
PURBShared pathway50%IFRD2Shared pathway50%ZAR1Shared pathway50%OOSP2Shared pathway50%PAIP2Shared pathway33%PAIP2BShared pathway33%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
24%
Lung
0%
Heart
0%
Ovary
0%
Liver
0%
Gene Interaction Network
Click a node to explore
ZAR1LPURBIFRD2ZAR1OOSP2PAIP2PAIP2B
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt A6NP61
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.91LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.59 [0.39–0.91]
RankingsWhere ZAR1L stands among ~20K protein-coding genes
  • #17,752of 20,598
    Most Researched8
  • #8,231of 17,882
    Most Constrained (LOEUF)0.91
Genes detectedZAR1L
Sources retrieved2 papers
Response timeβ€”
πŸ“„ Sources
2
1
Revisiting ZAR proteins: the understudied regulator of female fertility and beyond.
PMID: 35072788
Cell Mol Life Sci Β· 2022
1.00
2
Mouse ZAR1-like (XM_359149) colocalizes with mRNA processing components and its dominant-negative mutant caused two-cell-stage embryonic arrest.
PMID: 20014101
Dev Dyn Β· 2010
0.50